cGMPs / Large Molecule

Jury Deliberates on New England Compounding Murder Charges

Mar 14, 2017

Boston Globe

A federal jury is slated to begin deliberating tomorrow in the trial of Barry J. Cadden, the former New England Compounding Center head pharmacist and co-owner who is accused of causing the 2012 fungal meningitis outbreak that killed 64 people.

According to Law360, prosecutors allege that Cadden committed 25 counts of second-degree murder by skipping sterility tests, ignoring troubling environmental results and making drugs with long-expired ingredients, leading to the contamination of injectable steroids with mold.

Cadden is also being accused of defrauding the FDA by pretending that the New England Compounding Center was a pharmacy rather than a drug manufacturer.

Read the Boston Globe coverage